StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (0.00%)

Close on Nov 17, 2026Market cap $6.42MP/E –Yield –

Theriva Biologics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2010 it was -65.5%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2010Dec 31, 2010-65.5%–

More Theriva Biologics figures

See a number that looks wrong?